OCD Trial, Recruiting NCT06017713 Sponsor: Centre Hospitalier Henri Laborit Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06017713
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Obsessive-Compulsive Disorder (OCD) that has lasted for at least 2 years, based on standard medical guidelines.
  • You have a good level of self-awareness about your condition, meaning you recognise that your thoughts and behaviours are related to OCD (assessed using a specific scale — confirm with trial site).
  • You are not currently going through a depressive episode and are not at risk of suicide (confirmed using specific rating scales).
  • You do not have epilepsy.
  • Your OCD is considered severe, based on a standard OCD scoring tool called the YBOCS (confirm with trial site).
  • Your OCD has not responded to treatment — meaning you have tried at least 2 antidepressant medications at the right dose for long enough, and/or had Cognitive Behavioural Therapy (CBT) for at least 1 year without sufficient improvement.
  • Your medication has been stable (unchanged dose) for more than 12 weeks without significant improvement, and you would need to keep it the same during the study.
  • You are between 18 and 70 years old.
  • You have given your written, informed consent to take part after receiving information about the trial.
  • You are covered by social security or through a third party.

Who may not be able to join:

  • You are a woman of childbearing age and are not using an effective form of contraception (such as the pill, implant, coil, injection, patch, or surgical sterilisation).
  • You are pregnant or breastfeeding.
  • You are currently in hospital under a compulsory/involuntary psychiatric order.
  • You are under legal guardianship or a similar form of supervised legal protection.
  • You have another major mental health diagnosis such as Schizophrenia, Bipolar Disorder, or a current substance abuse or dependence problem — though generalised anxiety disorder, social phobia, nicotine addiction, or a history of depression do not automatically exclude you.
  • You are currently experiencing a depressive episode.
  • You are considered to be at risk of suicide.
  • You have skin lesions (wounds, sores, or broken skin) on your scalp.
  • You have a history of a significant head injury.
  • You have a metal object inside your skull or brain.
  • You have a pacemaker.
  • You have epilepsy.
  • You are in an emergency situation or unable to give your own consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 516526118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Henri Laborit
Registry
ClinicalTrials.gov
Start date
17 October 2023
Est. completion
1 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

YBOCS scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov